Arner P, Einarsson K, Ewerth S, Livingston J
J Clin Invest. 1986 May;77(5):1716-8. doi: 10.1172/JCI112492.
The insulin binding characteristics and the structural components of the insulin receptor were studied in the purified liver plasma membranes from seven patients with noninsulin-dependent diabetes (NIDDM) and seven control subjects. In comparison to the controls, diabetic subjects had a 65% reduction in plasma insulin levels in response to an oral glucose load. Specific insulin binding by liver membranes from diabetic patients was, however, twofold greater than the binding activity by membranes from control subjects. This alteration resulted largely from an increase in the number of insulin receptors and a modest increase in receptor binding affinity. Holo (nonreduced) receptor species of similar molecular weights were detected by an affinity labeling technique in the two membrane preparations and sulfhydryl reduction demonstrated an insulin binding subunit of 125,000 mol wt. Overall, these results show that the hepatic insulin resistance of NIDDM cannot be explained by a deficiency in insulin binding.
在来自7名非胰岛素依赖型糖尿病(NIDDM)患者和7名对照受试者的纯化肝细胞膜中,研究了胰岛素结合特性和胰岛素受体的结构成分。与对照组相比,糖尿病受试者口服葡萄糖负荷后血浆胰岛素水平降低了65%。然而,糖尿病患者肝细胞膜的特异性胰岛素结合比对照受试者膜的结合活性高两倍。这种改变主要是由于胰岛素受体数量增加以及受体结合亲和力适度增加。通过亲和标记技术在两种膜制剂中检测到分子量相似的全(非还原)受体种类,巯基还原显示出一个125,000道尔顿分子量的胰岛素结合亚基。总体而言,这些结果表明,NIDDM的肝脏胰岛素抵抗不能用胰岛素结合缺陷来解释。